A Double-Blind, Placebo-Controlled Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2018
Price : $35 *
At a glance
- Drugs Obeticholic acid (Primary)
- Indications Alcoholic hepatitis
- Focus Adverse reactions; Therapeutic Use
- Acronyms TREAT
- 06 Aug 2018 Status changed from recruiting to completed.
- 20 Mar 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Jul 2018.
- 04 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.